Delivery Order SPE2DB22D2006-SPE2DB25FW2RR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,727.91 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a $58,730.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human...
- The Defense Logistics Agency awarded a $53,530.13 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of October 23, 2025. This non-set-aside competitive award was issued on October 22, 2025, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the...
- The Defense Logistics Agency awarded a $27,168.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was issued on September 19, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the broad...
- The Defense Logistics Agency awarded a $15,696.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $25,916.48 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in HIV treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $23,421.82 on June 26, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procedures. The contract is set to conclude on June 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an HIV treatment...
- The Defense Logistics Agency awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by July 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an...
- The Defense Logistics Agency awarded a $77,677.53 delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed price contract with an ultimate completion date of September 29, 2025. This non-set-aside award was issued competitively on September 26, 2025, with performance based in Conshohocken, Pennsylvania. BIKTARVY is a brand-name antiretroviral medication used in the treatment of HIV infections, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,200.93 to supply BIKTARVY 50-200-25 mg tablets (30-count units) with delivery scheduled for October 23, 2025. This non-competitive, firm fixed-price delivery order was issued on October 22, 2025 and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2RRDelivery Order
The Defense Logistics Agency awarded a $36,289.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded on July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a brand-name antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's critical role in supplying pharmaceutical products to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's significant contract portfolio and competitive performance demonstrate its capability to fulfill federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.3k | 7/21/25 |